文献速递冠心病外科瓣膜外科

中度至重度缺血性二尖瓣反流:CABG联合二尖瓣手术的荟萃分析

Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-03-22

该荟萃分析比较了单纯冠状动脉旁路移植术(CABG)与CABG联合二尖瓣(MV)手术治疗中度至重度缺血性二尖瓣反流(IMR)的临床和超声心动图结局。纳入4项随机对照试验(n=505)和15项观察性研究(n=3785)。联合手术未增加围术期死亡率,随访中重度MR复发率显著降低,但远期死亡率无差异。

要点

  • CABG联合MV手术未增加围术期死亡率。
  • 联合手术显著降低随访期中重度MR复发率。
  • 两种策略的远期死亡率及超声心动图结局无显著差异。

核心结论

  • 在中度至重度IMR患者中,CABG联合MV手术未增加围术期死亡率。
  • 联合MV手术虽降低随访期中重度MR复发,但未降低远期死亡率。
  • 需要更大样本和更长随访的试验进一步评估长期生存和免于再干预。

研究设计与样本

  • 系统检索7个数据库,纳入报告围术期或远期死亡率终点的研究。
  • 纳入4项随机对照试验(n=505)和15项观察性研究(n=3785)。
  • 按预设临床终点进行数据分析。

主要发现

  • 围术期死亡率:联合手术 vs 单纯CABG,RCTs RR 0.89(95%CI 0.26-3.02),OS RR 1.40(95%CI 0.88-2.23)。
  • 随访期中重度MR发生率:联合手术显著更低,RCTs RR 0.16(95%CI 0.04-0.75),OS RR 0.20(95%CI 0.09-0.48)。
  • 远期死亡率:RCTs HR 1.20(95%CI 0.57-2.53),OS HR 0.99(95%CI 0.81-1.21)。
  • 超声心动图结局无显著差异。
  • 严格中度IMR亚组分析结果一致。

临床怎么用

  • 对于中度至重度IMR,CABG联合MV手术不增加围术期死亡风险。
  • 联合手术可减少随访期中重度MR复发,但未证实降低远期死亡率。
  • 决策需个体化权衡,并期待更长随访证据。

局限性

  • 纳入研究以观察性研究为主,存在混杂可能。
  • 随机对照试验样本量较小(n=505)。
  • 随访时间不足以充分评估长期生存和再干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This meta-analysis was conducted to compare clinical and echocardiographic outcomes following isolated coronary artery bypass grafting (CABG) versus CABG and mitral valve (MV) surgery in patients with moderate-to-severe ischemic mitral regurgitation (IMR). METHODS: Seven databases were systematically searched to identify relevant studies. For eligibility, studies were required to report on the primary endpoint of perioperative or late mortality. Data were analyzed according to predefined clinical endpoints. RESULTS: Four randomized controlled trials (RCTs) (n = 505) and 15 observational studies (OS) (n = 3785) met the criteria for inclusion. Compared with isolated CABG, concomitant CABG and MV surgery was not associated with increased perioperative mortality (RCTs: relative risk [RR] 0.89, 95% confidence interval [CI], 0.26-3.02; OS: RR 1.40, 95% CI, 0.88-2.23). CABG and MV surgery was associated with significantly lower incidence of moderate-to-severe MR at follow-up (RCTs: RR 0.16, 95% CI, 0.04-0.75; OS: RR 0.20, 95% CI, 0.09-0.48). Late mortality was similar between the surgical approaches in RCTs (hazard ratio [HR] 1.20, 95% CI, 0.57-2.53) and OS (HR 0.99, 95% CI, 0.81-1.21). There were no significant differences in echocardiographic outcomes. These results remained consistent in subgroup analyses restricted to patients with strictly moderate IMR. CONCLUSIONS: In patients with moderate-to-severe IMR, the addition of MV surgery to CABG was not associated with increased perioperative mortality. Although concomitant MV surgery reduced recurrence of moderate-to-severe MR at follow-up, this was not associated with a reduction in late mortality. Larger trials with longer follow-up duration are required to further assess long-term survival and freedom from reintervention.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Virk SA, Tian DH, Sriravindrarajah A, et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2017. PMID: 28549693. doi:10.1016/j.jtcvs.2017.03.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。